Skip to main content
SpringerLink
Log in

New Molecular Aspects in the Diagnosis and Therapy of Neuroendocrine Tumors of the Gastroenteropancreatic System

  • Conference paper
Peptides in Oncology III

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 153))

Abstract

The nature and biology of neuroendocrine cells and of tumors derived therefrom have been the subject of intense research using cell biological and molecular approaches. Diagnostic procedures for establishing the diagnosis of a neuroendocrine tumor have been improved through the development of new serological markers and imaging procedures. Histopathological diagnosis has been refined by the introduction of a broad spectrum of marker proteins for different subtypes of neuroendocrine neoplasms. The high receptor specificity of somatostatin analogues such as octreotide or lanreotide has made these drugs valuable tools in diagnosis and therapy, and some of the achievements made as well as future directions are reviewed in this article. Another substance in use for therapy of neuroendocrine tumors is interferon-a, whose signal transduction mechanism has been investigated considerably during the past several years. In addition to biotherapy with somatostatin analogues and/or interferon-a, chemotherapy is an accepted strategy in the treatment of advanced neuroendocrine tumor disease derived from the foregut. In this context, streptozotocin has caught some attention due to its somewhat selective toxicity against neuroendocrine tumor cells. Some recent studies on the role of the glucose transporter isoform GLUT2 may provide insight into streptozotocin's action. The multiple endocrine neoplasia type-1 gene has recently been cloned, sequenced and identified as a gene potentially involved in the development of the familial cancer syndrome of multiple endocrine neoplasia type 1 (MEN-1). Mutations of this putative tumor suppressor gene have been described, and the abundance of mutations in MEN-1-related tumors as well as sporadic neuroendocrine tumors at MEN-1 locations have been demonstrated. Whether determination of MEN-1 mutations will be valuable for clinical routine is under investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahlman H, Tisell LE, Wangberg B, Nilsson O, Forssell-Aronsson E, Fjalling M (1994) Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector. Semin Oncol 21 [Suppl 13]: 21–28

    PubMed  CAS  Google Scholar 

  • Ahlman H, Nilsson O, Wangberg B, Dahlstrom A (1996) Neuroendocrine insights from the laboratory to the clinic. Am J Surg 172: 61–67

    Article  PubMed  CAS  Google Scholar 

  • Ahnert-Hilger G, Grube K, Kvols L, Lee I, Monch E, Riecken EO, Schmitt L, Wiedenmann B (1993) Gastroenteropancreatic neuroendocrine tumours contain a common set of synaptic vesicle proteins and amino acid neurotransmitters. Eur J Cancer 29A: 1982–1984

    Article  PubMed  CAS  Google Scholar 

  • Ahnert-Hilger G, Stadtbaumer A, Striibing C, Scheriibl H, Schultz G, Riecken EO, Wiedenmann B (1996) γ-Aminobutyric acid secretion from pancreatic neuroendocrine cells. Gastroenterology 110:1595–1604

    Article  CAS  Google Scholar 

  • Arnold R, Frank M (1995) Systemic chemotherapy for endocrine tumors of the pancreas: recent advances. Front Gastrointest Res 23: 431–438

    Google Scholar 

  • Arnold R, Trautmann ME, Creutzfeld W, Benning R, Benning M, Neuhaus C, Jurgensen R, Stein K, Schafer H, Bruns C, Dennler HJ (1996) Somatostatin analogue octreotide and inhibition of tumor growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38: 430–438

    Article  PubMed  CAS  Google Scholar 

  • Bellmann K, Wenz A, Radons J, Burkart V, Kleemann R, Kolb H (1995) Heat shock induces resistance in rat pancreatic islet cells against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro. J Clin Invest 95: 2840–2845

    Article  PubMed  CAS  Google Scholar 

  • Borch K, Stridsberg M, Bur man P, Rehfeld JF (1997) Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Scand J Gastroenterol 32: 198–202

    Article  PubMed  CAS  Google Scholar 

  • Bordens R, Grossberg SE, Trotta PP, Nagabhushan TL (1997) Molecular and biologic characterization of recombinant interferon-α2b. Semin Oncol 24 [Suppl 9]:S9–41-S9–51

    Google Scholar 

  • Bouquet C, Delesque N, Lopez F, Saint-Laurent N, Esteve JP, Bedecs K, Buscail L, Vaysse N, Susini C (1998) sst2 Somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1. J Biol Chem 273:7099–7106

    Article  Google Scholar 

  • Bruno S, Crissman HA, Bauer KD, Darzynkiewicz Z (1991) Changes in cell nuclei during S phase: positive chromatin condensation and altered expression of the proliferation-associated nuclear proteins Ki67, cyclin PCNA, p105, and p34. Exp Cell Res 196: 99–106

    Article  PubMed  CAS  Google Scholar 

  • Calabresi P, Chabner BA (1991) Antineoplastic agents. In: Goodman Gilman A, Rail TW, Nies AS, Taylor P eds Goodman Gilman's the pharmacological basis of therapeutics, chap 52. Pergamon, New York, pp 1209–1263

    Google Scholar 

  • Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G (1995) Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 425: 547–560

    Article  PubMed  CAS  Google Scholar 

  • Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ (1997) Positional cloning of the gene for mtiltiple endocrine neoplasia-type 1. Science 276: 404–407

    Article  PubMed  CAS  Google Scholar 

  • Cordelier P, Esteve JP, Bousquet C, Delesque N, O’Carroll AM, Schally AV, Vaysse N, Susini C, Buscail L (1997) Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst 5. Proc Natl Acad Sci USA 94: 93439348

    Article  Google Scholar 

  • Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, Zhuang Z, Guru SC, Manickam P, Olufemi SE, Chandrasekharappa SC, Crabtree JS, Kim YS, Heppner C, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Collins FS, Travis WD, Emmert-Buck MR (1997) Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6: 2285–2290

    Article  PubMed  CAS  Google Scholar 

  • Deftos LJ, Linnoila RI, Carney DN, Burton DW, Leong SS, O’Connor DT, Murray SS, Gazdar AF (1988) Demonstration of chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay. Cancer 62: 92–97

    Article  PubMed  CAS  Google Scholar 

  • Dimaline R, Struthers J (1996) Expression and regulation of a vesicular monoamine transporter in rat stomach: a putative histamine transporter. J Physiol (Lond) 490: 249–256

    CAS  Google Scholar 

  • Eriksson B, Skogseid B, Lundqvist G, Wide L, Wilander E, Oberg K (1990) Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer 65: 1883–1890

    Article  PubMed  CAS  Google Scholar 

  • Eriksson B, Renstrup J, Imam H, Oberg K (1997) High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects. Ann Oncol 8: 1041–1044

    Article  PubMed  CAS  Google Scholar 

  • Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93: 5166–5171

    Article  PubMed  CAS  Google Scholar 

  • Fahrenkamp AG, Wibbeke C, Winde G, Ofner D, Bocker W, Fischer-Colbrie R, Schmid KW (1995) Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract. Virchows Arch 426: 361–367

    Article  PubMed  CAS  Google Scholar 

  • Faiss S, Scherubl H, Riecken EO, Wiedenmann B (1996a) Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system. Recent Results Cancer Res 142:193–207

    PubMed  CAS  Google Scholar 

  • Faiss S, Scheriibl H, Riecken EO, Wiedenmann B (1996b) Interferon-a versus somatostatin or the combination of both in metastatic neuroendocrine gut and pancreatic tumours. Digestion 57 [Suppl 1]:84–85

    Article  PubMed  CAS  Google Scholar 

  • Feyrter F (1938) Uber diffuse endokrine epitheliale Organe. Zbl Inn Med 59: 545

    Google Scholar 

  • Fraser RB, Rowden G, Colp P, Wright JR (1997) Immunophenotyplng of insulitis in control and essential fatty acid-deficient mice treated with multiple low-dose streptozotocin. Diabetologia 40: 1263–1268

    Article  PubMed  CAS  Google Scholar 

  • Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13–20

    Article  PubMed  CAS  Google Scholar 

  • Grimelius L (1968) A silver nitrate stain for α2 cells in human pancreatic islets. Acta Soc Med Upsal 73: 243–270

    PubMed  CAS  Google Scholar 

  • Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS, Chandrasekharappa SC (1998) Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 95: 1630–1634

    Article  PubMed  CAS  Google Scholar 

  • Haque SJ, Williams BRG (1998) Signal transduction in the interferon system. Semin Oncol 25 [Suppl 1]: 14–22

    PubMed  CAS  Google Scholar 

  • Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubenskv IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ (1997) Somatic mutation of the MEN1 gene in parathyroid tumors. Nature Genet 16: 375–378

    Article  PubMed  CAS  Google Scholar 

  • Hessman O, Lindberg D, Skogseid B, Carling T, Helloian P, Rastad J, Akerstrom G, Westin G (1998) Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial malignant tumors of the endocrine pancreas. Cancer Res 58: 377–379

    PubMed  CAS  Google Scholar 

  • Imam H, Gobi A, Eriksson B, Oberg K (1997) Interferon-alpha induces bcl-2 proto-onco-gene in patients with neuroendocrine gut tumor responding to its antitumor action. Anticancer Res 17: 4659–4665

    PubMed  CAS  Google Scholar 

  • John M, Meyerhof W, Richter D, Waser B, Schaer JC, Scheriibl H, Boese-Landgraf J, Neuhaus P, Ziske C, Moiling K, Riecken EO, Reubi JC, Wiedenmann B (1996) Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2 and 5. Gut 38: 33–39

    Article  PubMed  CAS  Google Scholar 

  • Jonas S, John M, Boese-Landgraf J, Haring R, Prevost G, Thomas F, Rosewicz S, Riecken EO, Wiedenmann B, Neuhaus P (1995) Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues. Langenbecks Arch Chir 380: 90–95

    Article  PubMed  CAS  Google Scholar 

  • Krenning EP, Kwekkeboom DJ, Oel HY, Dejong RJB, Dop FJ, Reubi JC, Lamberts SWJ (1994) Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. Ann NY Acad Sci 733: 416–424

    Article  PubMed  CAS  Google Scholar 

  • Lamberts SWJ, Reubi JC, Krenning EP (1994) The role of somatostatin analogues in the control of tumor growth. Semin Oncol 21 [Suppl 13]: 61–64

    PubMed  CAS  Google Scholar 

  • Langley K (1994) The neuroendocrine concept today Ann NY Acad Sci 733: 1–17

    Article  PubMed  CAS  Google Scholar 

  • Lembeck F (1953) 5-Hydroxytryptamine in a carcinoid tumor. Nature 172:910

    Article  CAS  Google Scholar 

  • Lloyd RV (1990) Endocrine pathology. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Masson P (1914) La glande endocrine de Pintestine chez fhomme. CR Acad Sci 158: 52–61

    Google Scholar 

  • McCarthy KE, Woltering EA, Espenan GD, Cronin M, Maloney TJ, Anthony LB (1998) In situ radiotherapy with 111 In-pentetreotide: initial observations and future directions. Cancer J Sci Am 4: 94–102

    PubMed  CAS  Google Scholar 

  • Meko JB, Norton JA (1995) Management of patients with Zollinger-Ellison syndrome. Ann Rev Med 46: 395–411

    Article  PubMed  CAS  Google Scholar 

  • Moertel CG (1987) An odyssey in the land of small tumors. J Clin Oncol 5: 1503–1522

    Google Scholar 

  • Nirenberg MJ, Liu Y, Peter D, Edwards RH, Pickel VM (1995) The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc Natl Acad Sci USA 92: 8773–8777

    Article  PubMed  CAS  Google Scholar 

  • Nobels FR, Kwekkeboom DJ, Coopmans W, Schoenmakers CH, Lindemans J, DeHerder WW, Krenning EP, Bouillon R, Lamberts SW (1997) Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-sub-unit of glycoprotein hormones. J Clin Endocrinol Metab 82: 2622–2628

    Article  PubMed  CAS  Google Scholar 

  • Nwokolo CU, Debnam ES, Booth JD, Sim R, Sankey EA, Dhillon AP, Pounder RE (1992) Neuroendocrine changes in rat stomach during experimental diabetes mellitus. Dig Dis Sci 37: 751–756

    Article  PubMed  CAS  Google Scholar 

  • Oberg K (1994) Expression of growth factors and their receptors in neuroendocrine gut and pancreas tumors, and prognostic factors for survival. Ann NY Acad Sci 733: 46–55

    Article  PubMed  Google Scholar 

  • Oberg K, Eriksson B, Janson ET (1994) The clinical use of interferons in the management of neuroendocrine gastroenteropancreatic tumors. Ann NY Acad Sci 733: 471–478

    Article  PubMed  Google Scholar 

  • Otte A, Mueller-Brand J, Delias S, Nitzsche EU, Herrmann R, Maecke HR (1998) Yttrium-90-labelled somatostatin analogue for cancer treatment. Lancet 351: 417–418

    Article  PubMed  CAS  Google Scholar 

  • Pearse AGE (1976) Peptides in brain and intestine. Nature 262: 92–94

    Article  Google Scholar 

  • Ransohoff RM (1998) Cellular responses to interferons and other cytokines: the JAK-STAT paradigm. N Engl J Med 338: 616–618

    Article  PubMed  CAS  Google Scholar 

  • Ranson WB (1890) A case of primary carcinoma of the ileum. Lancet 2: 1020

    Article  Google Scholar 

  • Reisine T, Bell GI (1995) Molecular biology of somatostatin receptors. Endocr Rev 16:427–442

    PubMed  CAS  Google Scholar 

  • Ren SG, Ezzat S, Melmed S, Braunstein GD (1992) Somatostatin analogue induces insulinlike growth factor binding protein-1 IGFBP-1 expression in human hepatoma cells. Endocrinology 131: 2479–2481

    Article  PubMed  CAS  Google Scholar 

  • Reubi JC (1997) Relevance of somatostatin receptors and other peptide receptors in pathology. Endocrine Pathol 8: 11–20

    Article  CAS  Google Scholar 

  • Schaer JC, Waser B, Mengod G, Reubi JC (1997) Somatostatin receptor subtypes sst1, sst2, sst3, and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography. Int J Cancer 70:530–537

    Article  PubMed  CAS  Google Scholar 

  • Scherubl H, Wiedenmann B, Riecken EO, Thomas F, Bohme E, Rath U (1994) Treatment of the carcinoid syndrome with a depot formulation of the somatostatin analogue lanreotide. Eur J Cancer 6: 1590–1591

    Article  Google Scholar 

  • Schnedl WJ, Ferber S, Johnson JH, Newgard CB (1994) STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43: 1326–1333

    Article  PubMed  CAS  Google Scholar 

  • Schurmann G, Raeth U, Wiedenmann B, Buhr H, Herfarth C (1992) Serum chromogranin A in the diagnosis and follow-up of neuroendocrine tumors of the gastroenteropancreatic tract. World J Surg 16: 697–702

    Article  PubMed  Google Scholar 

  • Simon B, Eissele R, Czornik M, Swarovsky B, Arnold R (1995) Effect of gastrin receptor blockade on gastrin and histidine decarboxylase gene expression in rats during achlohydria. Scand J Gastroenterol 30: 503–510

    Article  PubMed  CAS  Google Scholar 

  • Tang C, Biemond I, Lamers CB (1997) Expression of peptide receptors in human endocrine tumours of the pancreas. Gut 40: 267–271

    PubMed  CAS  Google Scholar 

  • Todisco A, Seva C, Takeuchi Y, Dickinson CJ, Yamada T (1995) Somatostatin inhibits AP-1 function via multiple protein phosphatases. Am J Physiol 269: G160–166

    PubMed  CAS  Google Scholar 

  • Toliat MR, Berger W, Ropers HH, Neuhaus P, Wiedenmann B (1997) Mutations in the MEN-I gene in sporadic neuroendocrine tumours of the gastroenteropancreatic system. Lancet 350: 1223

    Article  PubMed  CAS  Google Scholar 

  • Virgolini I, Raderer M, Kurtaran A, Angelberger P, Banyai S, Yang Q, Li S, Banyai M, Pidlich J, Niederle B, Scheithauer W, Valent P (1994) Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med 331: 1116–1121

    Article  PubMed  CAS  Google Scholar 

  • Wang Z, Gleichmann H (1998) GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 47: 50–56

    Article  PubMed  CAS  Google Scholar 

  • Wang DG, Johnston CF, Buchanan KD (1997) Oncogene expression in gastroenteropancreatic neuroendocrine tumors. Cancer 80: 668–675

    Article  PubMed  CAS  Google Scholar 

  • Wiedenmann B, Huttner WB (1989) Synaptophysin and chromogranins/secretogranins: widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Arch 58: 95–121

    Article  CAS  Google Scholar 

  • Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould V (1986) Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA 83: 3500–3504

    Article  PubMed  CAS  Google Scholar 

  • Wiedenmann B, Waldherr R, Buhr H, Hille A, Rosa P, Huttner WB (1988) Identification of gastroenteropancreatic neuroendocrine cells in normal and neoplastic human tissue with antibodies against synaptophysin, chromogranin A, secretogranin I chromogranin B, and secretogranin II. Gastroenterology 95: 1364–1374

    PubMed  CAS  Google Scholar 

  • Wiedenmann B, Bader HM, Scheriibl H, Fett U, Zimmer T, Hamm B, Koppenhagen K, Riecken EO (1994) Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy. Semin Oncol 21 [Suppl 13]: 29–32

    PubMed  CAS  Google Scholar 

  • Wiedenmann B, Jensen RT, Mignon M, Modlin CI, Skogseid B, Doherty G, Oberg K (1998) Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop. World J Surg 22: 309–318

    Article  PubMed  CAS  Google Scholar 

  • Zhao CM, Jacobsson G, Chen D, Hakanson R, Meister B (1997) Exocytotic proteins in enterochromaffin-like ECL cells of the rat stomach. Cell Tissue Res 290: 539–551

    Article  PubMed  CAS  Google Scholar 

  • Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Oldfield EH, Park WS, Pack S, Huang S, Agarwal SK, Guru SC, Manickam P, Debelenko LV, Kester MB, Olufemi SE, Heppner C, Crabtree JS, Burns AL, Spiegel AM, Marx SJ, Chandrasekharappa SC, Collins FS, Emmert-Buck MR, Liotta LA, Asa SL, Lubensky IA (1997a) Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 57: 5446–5451

    PubMed  CAS  Google Scholar 

  • Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park WS, Agarwal SK, Debelenko LV, Kester MB, Guru SC, Manickam P, Olufemi SE,Yu F, Heppner C, Crabtree JS, Skarulis MC, Venzon DJ,, Emmert-Buck MR, Spiegel AM, Chandrasekharappa SC, Collins FS, Burns AL, Marx SJ, Jensen RT, Liotta LA, Lubensky IA (1997b) Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57: 4682–4686

    PubMed  CAS  Google Scholar 

  • Zimmer T, Ziegler K, Bader M, Fett U, Hamm B, Riecken EO, Wiedenmann B (1994) Localisation of neuroendocrine tumours of the upper gastrointestinal tract. Gut 35: 471–475

    Article  PubMed  CAS  Google Scholar 

  • Zimmer T, Stolzel U, Bader M, Fett U, Foss HD, Riecken EO, Rehfeld JF, Wiedenmann B (1995) A duodenal gastrinoma in a patient with diarrhea and normal serum gastrin concentrations. N Engl J Med 333: 334–336

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Universitätsklinikum Charité, Campus Virchow-Klinikum, Medizinische Fakultät der Humboldt Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany

    U.-F. Pape, M. Höcker, U. Seuß & B. Wiedenmann

Authors
  1. U.-F. Pape
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Höcker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Seuß
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Wiedenmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin, Innere Medizin II (Hämatologie, Onkologie, Endokrinologie, Stoffwechselerkrankungen), Klinikum der Friedrich-Schiller-Uniersität Jena, Erlanger Allee 101, D-00740, Jena, Germany

    Klaus Höffken  & Roland Kath  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Pape, UF., Höcker, M., Seuß, U., Wiedenmann, B. (2000). New Molecular Aspects in the Diagnosis and Therapy of Neuroendocrine Tumors of the Gastroenteropancreatic System. In: Höffken, K., Kath, R. (eds) Peptides in Oncology III. Recent Results in Cancer Research, vol 153. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59587-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59587-5_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64038-4

  • Online ISBN: 978-3-642-59587-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation